About
Case45 develops AI models based on cancer evolutionary biology to predict oncology outcomes and treatment responses from routine histology slides, serving healthcare and pharmaceutical sectors with validated prognostic and predictive tests.
Explore Case 45's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.